Introduction
Large multi-subunit protein complexes with ATPdependent DNA translocase activity remodel and repair chromatin. There are four major classes of such complexes in mammals: (a) SWI/SNF, (b) INO80, (c) ISWI and (d) CHD families (reviewed in Refs [1] [2] [3] ). Each class is categorized by sequence similarity in their Abbreviations CHD, Chromodomain helicase DNA-binding protein; co-IP, co-immunoprecipitation; DTT, dithiothreitol; ELM, egl-27 and MTA1 homology; EM, electron microscopy; FLAG, epitope DYKDDDDK; GATAD2, Transcriptional repressor p66; GST, glutathione S-transferase; HA, human influenza haemagglutinin epitope YPYDVPDY; HDAC, histone deacetylase; HEK, human embryonic kidney; HRP, horseradish peroxidase; INO80, DNA helicase INO80; ISWI, imitation SWI; ITC, isothermal titration calorimetry; IVT, in vitro translation; MBD, Methy-CpG binding domain protein; MES, 2-(N-morpholino)ethanesulfonic acid; MTA, metastasis associated; NuRD, nucleosome remodelling and deacetylase complex; PBS, phosphate buffered saline; PEI, polyethyleneimine; RBBP, retinoblastoma-binding protein; RRL, rabbit reticulocyte lysate; SANT, SWIADA2, N-CoR, TFIIIB-B; SWI/SNF, SWItch/sucrose nonfermentable; XL-MS, crosslinking combined with mass spectrometry; Y2H, yeast two-hybrid system. translocase domain. Complexes from each class appear to have multiple functions in controlling gene transcription and repairing damaged DNA. Disrupting their activity results in significant impairment of growth, development and homeostasis.
The sets of proteins that comprise each class of complex are quite well defined. However, the arrangement of proteins within complexes and the mechanistic details that underpin their function is largely unknown. Low-resolution structures of complete or partial complexes have been derived from negativestain electron microscopy (EM) [4] [5] [6] [7] [8] [9] [10] [11] , but these have not been sufficient to derive a clear understanding of the remodelling process. It is also likely that these complexes are very dynamic, which hinders analysis by either crystallization or EM. Innovative approaches will be required to surmount this issue. In the absence of a high-resolution structure, a map of direct contacts between subunits, combined with knowledge of their structure and biochemistry, could provide a snapshot of the architecture of the complex. These data would enable the creation of models to propose and test functional and mechanistic hypotheses.
Inter-subunit connections have been defined by a number of methods; we estimate co-immunoprecipitations (coIPs), in vitro pulldown experiments and yeast two-hybrid analysis to be the most common. Covalent crosslinking combined with mass spectrometry identification (XL-MS) is increasingly popular. Biophysical analysis of purified proteins (e.g., by surface plasmon resonance, NMR or titration calorimetry) is used mostly to confirm interactions defined by other methods. For all approaches, accurate interpretation of observations requires careful consideration of the experimental strengths and weaknesses. The known structure and biochemistry of the proteins concerned must also be taken into account.
The nucleosome remodelling and deacetylase (NuRD) complex is a CHD-class complex that is conserved among complex animals. It is important for development, stem cell biology and DNA repair [12] [13] [14] . The complex has six core subunits, each with several paralogues: the DNA translocase CHD4 (or -3 or -5), HDAC1 (or -2), MTA1 (or -2 or -3), GATAD2A (or -B), RBBP4 (or -7) and MBD2 (or -3) (Fig. 1) . Structural data on subcomplexes of NuRD are becoming available [15] [16] [17] [18] [19] , but no structure of the intact complex exists. Since 1998, a considerable body of subunit interaction data has been built up that relies on the methods described above. However, we propose that there are issues in these experimental approaches that lead to either false negatives or, more often, false positives. We surveyed the literature to catalogue reported pairwise interactions between NuRD subunits and assessed the reliability of these methods through our own subunit interaction studies. As a result, herein we present a set of high-confidence direct inter-subunit interactions. With this set, we propose a model for the overall architecture of the NuRD complex. We also highlight inherent flaws in methods that are widely considered to be reliable for defining protein-protein interactions.
Results

Assessing reported NuRD subunit interactions: choice of expression system
Our survey of the literature found 45 papers describing experiments that define interactions between core NuRD subunits. Tables 1 and 2 and Fig. 2A summarize the data from these studies. In several papers (e.g., [20, 21] ), proteins were expressed in bacteria, as is common for biochemical and structural analysis of proteins and protein complexes. However, it is often overlooked that the presence of soluble protein from bacterial expression does not guarantee correct folding. Soluble, partially folded aggregates often form and can bind nonspecifically to other proteins [22] . Affinity tags can also impact folding, leading to nonspecific interactions [23] . Recently, a 'cloning scar' in a commercially available ORF library was shown to lead to aberrant co-purification of endogenous proteins [24] .
For a well-studied protein, an absence of biochemical or biophysical data in the literature for bacterially produced protein is a likely indicator that the protein is not amenable to bacterial expression. For example, several structures of histone deacetylase (HDAC)-containing complexes have been determined recently [15, 19, 25] , and two groups have reported structures of RBBP4 and RBBP7 [17, 26, 27] ; all have used eukaryotically expressed proteins. Similarly, no structures have been reported for domains in MTA1 other than the HEK293-expressed complex with HDAC1 [15] . Finally, despite extensive trials, our laboratories have never successfully expressed folded HDACs, RBBPs or MTAs (either domains or full-length proteins) in bacteria (JPM and DCW, unpublished data).
A number of published studies have examined intersubunit interactions in NuRD using bacterially expressed subunits. With the above caveats in mind, it is our view that such observed interactions are in general not reliable. We have graded reported subunit interactions in Table 1 to account for the uncertainty introduced by the use of bacterially expressed proteins and, as discussed in the next section, by bridging interactions.
Assessing reported NuRD subunit interactions: the issue of endogenous components
The delineation of direct interactions between overexpressed components of a multi-protein complex can be compromised by the presence of either the endogenous complex or other interacting proteins in the chosen expression system; for eukaryotic proteins, this issue can be particularly significant for expression in insect or mammalian cells. Endogenous proteins could bridge the two subunits of interest, giving the false impression of a direct interaction. In the same vein, co-immunoprecipitations (coIPs) are often regarded as the 'gold standard' for detecting the presence of a physiologically relevant interaction [28] ; they are convenient and use small quantities of cells. However, western blots are almost always used for detection. These can be misleading because host-derived proteins (or other bridging macromolecules) that might be present will not be detected.
This issue, which we believe affects many studies describing protein-protein interactions, is illustrated in Fig. 3 . As part of an effort to probe NuRD complex architecture, we asked whether direct RBBP4-RBBP4 interactions can take place. We co-expressed FLAG-tagged RBBP4 (FLAG-RBBP4) and HAtagged RBBP4 (HA-RBBP4) in HEK293 cells, and anti-FLAG beads were used to capture FLAG-RBBP4. Western blot analysis of the eluate with anti-HA antibody showed that HA-RBBP4 co-purified with FLAG-RBBP4 (Fig. 3A) , suggesting that RBBP4 forms homo-oligomers. However, when the gel was stained with SYPRO Ruby, numerous other proteins were observed (Fig. 3B) , even under more stringent conditions (500 mM NaCl, Fig. 3C,D) . The molecular weights of several of these additional proteins correlate with other NuRD subunits, and their identity was verified with western blots (Fig. 3A,C) . These data indicate that endogenous NuRD components can associate with overexpressed FLAG/HA-RBBP4, illustrating how a NuRD-type complex can assemble from endogenous and overexpressed components. Therefore, from this set of experiments, it cannot be concluded that two RBBPs directly interact. In fact, we and others have demonstrated that MTA1 can simultaneously bind two molecules of RBBP4/7 [18, 19] , indicating that the apparent RBBP-RBBP interaction is likely to be indirect -mediated by MTA1/2/3. We have observed a similar phenomenon when probing [40] for other interactions between pairs of subunits, including CHD4 and RBBP7 (Fig. 3E ). Many published studies report 'direct' interactions between NuRD complex subunits using proteins coexpressed in mammalian cells (Table 1 ). For example, Gong et al. [29] showed GATAD2A/B interact with GST-tagged RBBP4/7, HDAC1 or MBD3. Their data consisted of pairwise HEK293 co-transfections and GST affinity pulldowns with western blot analysis. Similarly, Taplick et al. [30] detected endogenous HDAC1 by western blot when purifying recombinant HDAC1 from 3T3 cell lysates. They concluded that HDAC1 self-associates. However, the HDAC1-MTA1 crystal structure (see below, [15] Table 1 . (B) Representation of the XL-MS data presented in Table 2 , taken from either [40] (red lines) or [19] (blue lines). Proteins are coloured in a similar way to Fig. 1 .
HA-RBBP4
FLAG-RBBP4 , but anti-FLAG beads were washed with 500 mM NaCl during purification. Even under these higher stringency conditions, endogenous NuRD components were observed. (E) CoIP assessing a possible interaction between CHD4C1C2 (residues 1230-1912) and RBBP7. FLAG-CHD4C1C2 and HA-RBBP7 were co-expressed in HEK293 cells and FLAG-CHD4C1C2 was purified with anti-FLAG beads. Detection with anti-FLAG or anti-HA antibodies (top two panels) suggests a direct CHD4-RBBP7 interaction. However, endogenous NuRD components, which could be bridging the interaction, were also detected in the lower blot, which was run with a sample from the same pulldown and developed as in the lower panel in (A).
of HDAC1 that are bridged by an MTA1 dimer; direct HDAC1-HDAC1 interactions do not occur.
An improved NuRD subunit interaction map derived from in vitro translated proteins
To address the artefacts caused by incorrect folding and endogenous complex components, we expressed NuRD subunits in vitro using rabbit reticulocyte lysate (RRL) with coupled transcription-translation. We reasoned that RRL is mammalian and more likely to produce correctly folded NuRD components than Escherichia coli. In addition, reticulocytes lack a nucleus and should have reduced quantities of NuRD components. Consistent with this hypothesis, we could not detect HDAC1 or MTA1 in the lysate by western blot, and only negligible quantities of RBBP4/7 ( Fig. 4A ). In contrast, NuRD subunits could be readily detected in HEK293 cell lysates and also in a pulldown from HEK293 cells using FOG1(1-45) (which selectively enriches the NuRD complex from cell extracts [31] [32] [33] ) as bait.
Using RRL, we conducted a pairwise interaction screen of all NuRD subunits: CHD4, HDAC1, MTA1/ 2, RBBP4/7, GATAD2B and MBD3. Our experimental design took into account the HDAC1-MTA1(162-335) structure [15] . The extensive HDAC1-MTA1(162-335) interface suggests that HDAC1 expressed in the absence of MTA1(162-335) might fold incorrectly or spuriously bind other proteins. The absence of an 'HDAC1-alone' crystal structure also hints at difficulties expressing recombinant HDAC1 (even in eukaryotic hosts). Thus, as a precaution, we only assessed HDAC1 interactions with MTA2N (residues 1-429) present. Figure 4B shows pulldowns carried out with FLAG-RBBP4 as bait and one of MTA2, GATAD2B, MBD3cc (a fusion of MBD3 and the coiled-coil region of GATAD2A, see Materials and methods and Ref. [34] ) or HDAC1 + MTA2N as the prey. For comparison, Fig. 4C shows pulldowns using the same proteins co-expressed in HEK293 cells. Using the RRL system, RBBP4 interacts with MTA2 (consistent with [17] [18] [19] ) but not with GATAD2B, MBD3cc or the HDAC1 + MTA2N complex. In contrast, and in line with the previous section, RBBP4 appeared to interact with every subunit tested in the HEK293 pulldowns. Figure 5A summarizes the results of the RRL subunit interaction screen. Due to the large size of CHD4 (~1900 residues), we were unable to express the fulllength protein in RRL. Therefore, the protein was divided into three polypeptides (shown in Fig. 1 ): CHD4N (residues 1-355), CHD4M (residues 355-1230) and CHD4C1C2 (residues 1230-1912). The cut sites avoided crossing known domains or predicted secondary structures. CHD4N contains the recently reported HMG-box-like domain [35] , CHD4M contains the PHD, chromo-and helicase domains and CHD4C1C2 contains two predicted helical domains with unknown folds or function. Figure 5B shows the western blots for which positive interactions were observed, while the rest of the pulldowns performed are shown in Figs 4B and 6. We observed five pairwise interactions: MTA2 and MTA2, MBD3 and MTA2, RBBP4 and MTA2, GATAD2B and MBD3, and CHD4C1C2 and GATAD2B.
To further refine the set of observed interactions, we divided MTA2, CHD4C1C2 and GATAD2B into shorter fragments (shown in Fig. 1 ): MTA2N (residues 1-429), MTA2C (residues 437-639), CHD4C1 (residues 1230-1540), CHD4C2 (residues 1686-1902), GATAD2Ba (residues 1-276), GATAD2Bb (residues 1-473), GATAD2Bc (residues 86-593), GATAD2Bd (residues 276-593) and GATAD2Be (residues 276-473). Figure 5C summarizes the results of pulldowns with these fragments and Fig. 5D shows the corresponding western blots. RBBP4 interacted with MTA2C but not MTA2N, whereas CHD4C2 but not CHD4C1 interacted with GATAD2B. Furthermore, GATAD2Bb, GATAD2Bc, GATAD2Bd and GATAD2Be but not GATAD2Ba bound CHD4. In line with these results, we also observed an interaction between GATAD2Af (residues 339-633) expressed in mammalian cells and endogenous CHD4 (Fig. 5E) . No other bridging NuRD components were detected in this pulldown, consistent with the interaction being direct. This positive result with full-length CHD4 also complements the RRL experiments, given that we were unable to express fulllength CHD4 in the RRL system. Surprisingly, HDAC1 did not show an interaction with any NuRD components, including MTA1 or MTA2. To test if this was due to incorrect folding of RRL-produced HDAC1, we conducted a deacetylase assay (Fig. 7) . Our results showed that RRL-produced HDAC1, when in isolation, has negligible deacetylase activity. When co-purified with MTA2N, some activity is observed, but significantly higher activity is observed when HDAC1 is immunoprecipitated from mammalian cells. From these data, we conclude that a large proportion of RRL-prepared HDAC1 does not form active enzyme, consistent with our observation that HDAC1 did not show reliable interactions with any of the NuRD components, including its high-confidence interaction partner MTA1/2. We do note, however, that the increase in HDAC1 deacetylase activity following co-expression with MTA2N suggests that at least a small fraction of RRL-derived HDAC1 can interact with MTA2. This observation also underscores the high sensitivity of enzyme assays as a means to assess correct folding.
The folding considerations of RRL-produced HDAC1 raise the question of whether the other NuRD subunits expressed by this method are correctly folded and able to establish native interactions. However, it is significant that we only observed very few positive hits relative to the large number of negative hits (six positive hits from 29 crosses, Fig. 5A ). This suggests some specificity in the observed interactions. In addition, of the six positive hits, three agree well with what we consider as high-confidence published data. The remaining three describe two new interactions (between MBD3 and MTA2, and between CHD4 and GATAD2B) which, as described above, were further analysed and confirmed using a number of different constructs (Fig. 5C) ; the use of different constructs reduces the likelihood of false-positive interactions due to misfolding of a particular construct. It is noteworthy that we also observed consistent negative hits in these followup constructs. Taken together, all these point to the detected positive interactions to be bona fide interactions. If anything else, our setup makes it more likely to have more false negatives than false-positive interactions, an example of which is our failure to detect the high-confidence MTA-HDAC interaction, as discussed above.
Discussion
How reliable are reported NuRD subunit interactions?
False-positive protein-protein interactions arising from bridging or nonspecific interactions can become embedded in the literature through subsequent citation Corresponding western blots of all tested interactions as summarized in (C). RBBP4 was observed to interact with MTA2C and GATAD2B with CHD4C2. The interaction between GATAD2B and CHD4C2 was then further narrowed down to the residues 276-473 of GATAD2B (construct GATAD2Be). Bait proteins have been denoted with *, while the prey proteins, if observed in the pulldown lane (PD), have been denoted with +. Where the bait and prey proteins are of similar molecular masses, the corresponding aHA-only blot is provided. (E) Immunoprecipitations using FLAG-GATAD2Af (339-633) as bait in transfected HEK293 cells. The western blots were incubated with the antibodies indicated on the left. GATAD2Af is able to pull down CHD4 but not other NuRD components. IgG: negative control using IgG for the immunoprecipitation. Note that in all cases, the relative intensities of bait and prey bands do not correlate with the concentrations of the relevant proteins because of the different activity of the anti-FLAG and anti-HA antibodies.
and incorporation into interaction databases and can significantly skew interactome maps, complicating the process of delineating bona fide interactions. Fundamentally, these problems arise when insufficient controls are conducted. For example, correct folding of proteins used in pulldowns/coIPs is rarely assessed. We suggest that many researchers associate aggregation with precipitation, therefore inferring that soluble proteins are correctly folded. One's confidence in a reported protein-protein interaction should, therefore, take into account whether or not evidence of correct folding is given, especially for proteins that do not have structural or biophysical data available. This evidence could be biophysical (e.g., circular dichroism spectropolarimetry or one-dimensional 1 H NMR spectroscopy) or functional (e.g., binding to other partner molecules or enzyme activity). Frequently, this might require proteins to be produced and purified in larger quantities, which might not be practical. Corroborating data from other labs showing functional proteins can be expressed and purified in the same system are also valuable.
Overall, we recommend that, when reporting proteinprotein interactions by pulldown analysis, the question of whether proteins are correctly folded is addressed whenever possible. Additionally, gels stained for total protein would help detect possible bridging proteins. In our system, approximately one million HEK293 cells (0.25 mL of culture for suspension-adapted cells) produced goodquality SYPRO-stained gels for NuRD interactors. This is a reasonable quantity for most situations. Unfortunately, the quantities of protein typically produced in the RRL system are too small to readily permit biophysical analysis or SYPRO staining. In this study, for example, we were only able to directly assess the folding of HDAC1 using an enzymatic activity assay. However, existing structural and biochemical data served to increase our confidence in the conclusions that we drew about NuRD subunit interactions.
A refined subunit interaction map for the NuRD complex
RRL is a eukaryotic and cell-free system for the production of recombinant proteins. In our experience, balancing the possibility of incorrect folding with bridging issues, we find interactions detected by RRL to be a good compromise that yields higher overall confidence than those detected in cellular expression systems.
Our results suggest that, contrary to the picture that a survey of the literature paints, the NuRD complex is constructed from relatively few direct inter-subunit interactions. Encouragingly, our data here agree closely with existing (orthogonal) structural data. That is, interactions between RBBP4 and the C-terminal half of MTA1 have been observed in several studies (Table 1 and [17] [18] [19] ), MBD3 and GATAD2B are known to interact through a short coiled-coil (analogous to the MBD2-GATAD2A interaction [16] ) and the ELM-SANT domain region of MTA1/2 homodimerizes in the HDAC-MTA1 structure [15] .
The other two observed pairwise interactions, MBD3-MTA2 and CHD4-GATAD2B, have not been structurally characterized. MBD3 was reported to bind MTA2 [21, 37] , although one of the studies ( [21] ) used MTA2 expressed in E. coli, which was probably not well-folded (based on extensive work done on MTA1/ 2 in our labs; data not shown). CHD4 has not been observed previously to bind GATAD2B or GATAD2A in the mammalian NuRD complex. Here, we have localized this interaction to a predicted helical domain within the C terminus of CHD4. Our data suggest that GATAD2B (276-473), which contains a GATA-type zinc finger and a predicted coiled coil, is the region interacting with CHD4. It is notable that the COILS server [38] predicts two coiled-coil motifs with moderate confidence within the CHD4C2 region.
To clarify the major contacts made in the NuRD complex, we combined our RRL data with existing high-confidence interactions observed in 3D structures. We also considered information from XL-MS (Table 2 and Fig. 2B) [19, 39, 40] . In two studies using XL-MS on intact NuRD complex [39, 40] , five interactions were identified by multiple independent crosslinks, namely MTA1/2/3-RBBP4/7 (> 10 crosslinks), GATAD2A/B-MBD3 (5), MTA2-MBD3 (3), GATAD2A/B-CHD3/4 (6) and MTA1/2-CHD3/4 (4). The first two corroborate both our RRL data and existing 3D structures. The third and fourth corroborate interactions observed in our RRL experiments. Further, five of the six crosslinks between CHD4 and GATAD2A/B directly reflect our observed interaction between CHD4C2 and GATAD2Bb/c. In addition, XL-MS data for a recombinant HDAC1-MTA1-RBBP4 complex show multiple connections between HDAC1 and both MTA1 and RBBP4 [19] . Crosslinks observed within a multi-protein complex do not unambiguously imply two proteins directly interact. However, agreement between pulldown and XL-MS data from different studies increase one's confidence that a direct interaction exists. Figure 8 summarizes NuRD subunit interactions from known structures, our RRL screen and reported XL-MS data. Each connection is corroborated by two orthogonal methods, except HDAC-RBBP and CHD-MTA (see below), giving rise to a highly self-consistent map of inter-subunit interactions within the NuRD complex.
A model of the NuRD complex
Several recent papers report structures of NuRD subcomplexes (Fig. 9A,B) . Gnanapragasam et al. [16] determined the structure of the MBD2-GATAD2A coiled coil by NMR spectroscopy. Millard et al. [15] showed by X-ray crystallography that HDAC1 forms a dimer of dimers with the MTA1 ELM and SANT domains [MTA1(162-335)]. Subsequently, they showed by negative-stain single-particle EM that a longer MTA1 polypeptide [MTA1(162-546)] allows the HDAC1-MTA1 dimer to bind two RBBP4 subunits in a 2 : 2 : 2 fashion (HDAC:MTA:RBBP; Fig. 9B ) [19] . We showed through multiple approaches including single-particle EM that MTA1(449-715) binds two RBBP molecules simultaneously (Fig. 9B) [18] .
Together, these structural data suggest that a HDAC-MTA-RBBP subcomplex containing full-length MTA has a 2 : 2 : 4 stoichiometry. This stoichiometry was also observed recently for the homologous Drosophila melanogaster complex, using multiangle laser light scattering (MALLS) and label-free iBAQ quantitative MS [41] . Two papers from the Vermeulen laboratory also used iBAQ MS to estimate the subunit stoichiometry of the mammalian NuRD complex [39, 40] . These studies reported HDAC:MTA ratios of 1 : 3 [39] and~2 : 2.5 [40] , the second of which is more consistent with the ratio inferred above. Using these data, we constructed a simple model of the 2 : 2 : 4 HDAC-MTA-RBBP subcomplex that is suggested by the structural data (Fig. 9C) . This model, like the HDAC1-MTA1 structure, has a two-fold axis of rotational symmetry. It is also likely that the MTA-(RBBP) 2 units (blue) exhibit some dynamics relative to the HDAC-MTA unit, perhaps allowing them to engage effectively with nucleosomal substrates during remodelling.
The observed interaction between the CHD4C2 domain and GATAD2 in our RRL screen and in published XL-MS data point to a model in which the MBD-GATAD2 dimer connects CHD4 to the HDAC-MTA-RBBP unit. A similar suggestion has been made based on work on Drosophila NuRD [41] . Further, the observation that immunoprecipitation of GATAD2Af from mammalian cells pulls down CHD4 but no other NuRD components (Fig. 5E) suggests that the connection between CHD4 and the rest of the NuRD complex is predominantly through the GATAD2Af region, not via multiple interactions with other subunits.
In contrast, the stoichiometry of GATAD2 and MBD relative to HDAC-MTA-RBBP is less clear. A 1 : 1 ratio of GATAD2 and MBD is observed in the coiled-coil NMR structure. This ratio is corroborated in the label-free iBAQ quantitative MS of Kloet et al. [40] . The same paper also observes a 2 : 2 for HDAC: MBD, suggesting two MBD-GATAD2 units might exist in a single NuRD complex. In contrast, however, MALLS and iBAQ data on D. melanogaster NuRD argue for a 2 : 1 HDAC:MBD ratio and a substoichiometric amount of GATAD2 [41] . A substoichiometric GATAD2 is unlikely; we have previously shown, using blue-native-PAGE (BN-PAGE) and two-dimensional BN-SDS-PAGE, that GATAD2 is associated with the NuRD complex in all its forms (including the CHD-less NuDe complex) [32] . This apparent discrepancy might be attributable to biological differences between the mammalian and fly NuRD.
On balance, we favour a HDAC : MBD : GATAD2 ratio of 2 : 1 : 1 for two main reasons: (a) the 1 : 1 MBD : GATAD2 ratio has been observed in a highresolution NMR structure, a method that is in general preferable for quantification purposes to MS-based techniques; (b) despite the possible differences between fly and mammalian NuRD, the HDAC : MBD data obtained by Zhang et al. were based on two orthogonal methods, whereas Kloet et al. had used MBD as [15] [16] [17] 19] . Thin lines: interactions observed in our screen carried out using RRLproduced proteins. Dashed lines: interactions suggested by at least three crosslinks in XL-MS studies [19, 40] [17] , NMR structure of MBD2-GATAD2A coiled-coil (PDB ID: 2L2L) [16] , and X-ray structure of the nucleosome (PDB ID: 1EQZ). (B) Single-particle EM envelopes for the (HDAC1-MTA1-RBBP4) 2 subcomplex (PDB ID: 5FXY and EMDB ID: EMD-3399) [19] and the MTA1-(RBBP4) 2 subcomplex (EMDB ID: EMD-3431) [18] . The structures have been rendered as a reduced resolution envelope by applying a Gaussian filter in Chimera [36] . X-ray crystal structures of HDAC1-MTA1 and RBBP4 have been fitted into the maps using the 'fit' function in Chimera. (C) Model of an (HDAC1-MTA1) 2 -RBBP4 4 subcomplex generated using two copies of the MTA1-(RBBP4) 2 model, and superimposing an RBBP4 subunit from each copy onto each RBBP4 in the (HDAC1-MTA1-RBBP4) 2 model. (D) Model of the NuRD complex generated using the subcomplex in (C) and positioning MBD3, GATAD2A and CHD4 in agreement with the observed protein-protein interactions. MBD3 (dark blue) bridges MTA1 and GATAD2A (orange), while GATAD2A contacts the C-terminal third of CHD4 (green). MBD3 is represented by the MBD2:GATAD2A structure and the MBD domain of MBD3 (PDB ID: 2MB7). A density envelope derived from a disordered polypeptide chain was used to depict GATAD2A. the purification 'handle' -this could have led to excess MBD that complicated quantification. Together, these data suggest an overall stoichiometry for the NuRD complex of 2 : 2 : 4 : 1 : 1 : 1 (HDAC : MTA : RBBP : MBD : GATAD2 : CHD). We have created an indicative model based on these data (Fig. 9D ) that docks the MBD-GATAD2 dimer with the N-terminal region of MTA, consistent with our RRL pulldown data. We also show a nucleosome in this image, and it is easy to imagine how interactions made with the nucleosome by the histone-and DNA-binding sites of RBBP, MBD and MTA subunits could position the single CHD4 translocase enzyme to act on the DNA. It is also likely that the substrate preferences of entities such as the PHD domains of CHD4 and the RBBP subunits will play a role in determining the preferred remodelling targets of NuRD. A more complete model, and from it, a better understanding of the biochemical mechanism by which NuRD remodels chromatin, awaits detailed structural and biophysical analysis of the intact complex.
Materials and methods
Plasmids
The pcDNA3.1 expression vector was used for suspensionadapted HEK Expi293F
™ cell expression and in vitro RRL transcription-translation. Full-length genes for human HDAC1 (UniProt ID: Q13547) and human CHD4 (UniProt ID: Q14839) with an N-terminal FLAG-tag were kind gifts from Gerd Blobel. These constructs were subcloned to substitute the FLAG-tag for a HA-tag. Full-length genes for human RBBP4 (UniProt ID: Q09028), human RBBP7 (UniProt ID: Q16576), mouse MTA2 (UniProt ID: Q9R190), human MTA1 (UniProt ID: Q13330), mouse GATAD2B (UniProt ID: Q8VHR5), human GATAD2B (UniProt ID: Q8WXI9) and mouse MBD3 (UniProt ID: Q9Z2D8) were cloned with N-terminal FLAG and HA tags. We also generated a construct, MBD3cc, consisting of murine MBD3 fused to residues 133-174 of mouse GATA2DA (UniProt ID: Q8CHY6). This region of GATA2DA has been previously shown to form a coiledcoil interaction with MBD3 [42] . We hypothesized that fusing this region of GATA2DA to MBD3 could stabilize and improve expression of MBD3. Shorter constructs were also generated from these full-length genes: MTA2N ( Expression Medium (Thermo Fisher Scientific). Combinations of equimolar quantities of plasmids were co-transfected into cells using linear 25-kDa polyethylenimine (PEI) (Polysciences, Warrington, PA, USA). 3.8 lg of DNA mix was first diluted in 205 lL of PBS and vortexed briefly. 7.6 lg of PEI was then added and the mixture was vortexed again, incubated for 20 min at room temperature, and then added to 1.9 mL of HEK cell culture. The cells were incubated for 65 h at 37°C with 5% CO 2 and horizontal orbital shaking at 130 rpm. One millilitre aliquots of cells were then harvested, washed twice with PBS, centrifuged (300 g, 5 min), snap-frozen in liquid nitrogen and stored at À80°C. Lysates were prepared by sonicating thawed cell pellets in 0.5 mL of lysis buffer (50 mM Tris/HCl, 150 or 500 mM NaCl, 1% (v/v) Triton X-100, 1 9 cOmplete Ò EDTA-free protease inhibitor (Roche, Basel, Switzerland), 0.2 mM DTT, pH 7.9), incubating on ice for 30 min to precipitate chromatin and then clarifying the lysate via centrifugation (≥ 16 000 g, 20 min, 4°C). The cleared supernatant was used for FLAG-affinity pulldowns as described below. Alternatively, adherent HEK293T cells were transfected with the plasmid pCMV-Tag2b-GATAD2Af. At 48 h post transfection, the cells were lysed in micrococcal nuclease (MNase) digestion buffer (25 mM HEPES-KOH pH 7.6, 100 mM NaCl, 5 mM MgCl 2 , 3 mM CaCl 2 , 10% (v/v) glycerol, 0.2% (v/v) NP40 and 1 9 EDTA-free protease inhibitor cocktail (Roche)) and then subjected to MNase digestion using 1500 UÁmL À1 of MNase (Worthington Biochemical, Lakewood, NJ, USA) for 2 h on ice. Ethidium bromide was then added to the lysate at 300 lgÁmL À1 followed by centrifugation at 10 000 g for 15 min at 4°C.
In vitro rabbit reticulocyte lysate protein expression
Proteins were expressed in vitro using the TNT Ò Quick Cou- When adherent HEK293T cells were used, the cleared cell lysate was subjected to immunoprecipitation with antiflag M2 antibody (F1804; Sigma-Aldrich, St. Louis, MO, USA) and mouse IgG (Santa Cruz Biotechnology, Dallas, TX, USA) control according to the Sigma Flag-IPT kit protocol (Sigma-Aldrich).
Immunoprecipitation of proteins produced in rabbit reticulocyte lysates
Twenty microlitres of anti-FLAG Sepharose 4B beads (Biotool) (pre-equilibrated with 50 mM Tris/HCl, 150 mM NaCl, 0.1% (v/v) Triton X-100, 19 cOmplete Ò EDTA-free protease inhibitor (Roche), 1 mM DTT, pH 7.5) was added to 50-75 lL RRL reactions. The mixtures were incubated overnight at 4°C with orbital rotation. Postincubation, the beads were washed with 5 9 800 lL 'wash' buffer (50 mM Tris/HCl, 150 mM NaCl, 0.5% (v/v) IGEPAL Ò CA630, 1 mM DTT, pH 7.5). Bound proteins were eluted by 2 9 20 lL treatment with 'elution' buffer (50 mM Tris/ HCl, 150 mM NaCl, 10% (v/v) glycerol, 1 mM DTT, 300 lgÁmL À1 3 9 FLAG peptide (MDYKDHDG-DYKDHDIDYKDDDDK), pH 7.5) for 30 min on ice. Elution fractions were pooled for downstream analyses.
SDS/PAGE and western blot analysis
Samples of Expi293F
™ lysates/RRL reactions, anti-FLAG bead washes and protein elutions were subjected to protein gel electrophoresis using Bolt 
HDAC activity assays
The in vitro translation (IVT)-produced samples analysed in the HDAC activity assays were prepared as described above. For the HEK293 extract control, a cleared cell lysate was prepared from 1 9 10 6 nontransfected Expi293F ™ cells (Thermo Fisher Scientific) as described above. In both cases, HDAC1 was enriched by an anti-HDAC1 immunoprecipitation before the assays as follows. For each sample, 20 lL of protein A/G magnetic beads (Biotool) was washed three times with 500 lL buffer A (50 mM Tris/HCl, 150 mM NaCl, 0.1% (v/v) Triton X-100, pH 7.5). Anti-HDAC1 (0.5 lL, Cell Signalling Technology 5356S) was diluted in 25 lL of buffer A, and the mixture added to the washed beads and rotated for 3 h at 4°C. The beads were then washed twice with 500 lL buffer A, and incubated with the IVT reactions or HEK293 cleared lysates overnight at 4°C. Postincubation, the beads were washed with 5 9 800 lL 'wash' buffer (50 mM Tris/HCl, 150 mM NaCl, 0.5% (v/v) IGEPAL Ò CA630, 1 mM DTT, pH 7.5), and finally resuspended in 60 lL of 10 mM HEPES, 150 mM NaCl, 1 mM DTT, pH 7.5. Deacetylase activity of two-three separate preparations of each sample was measured using a HDAC activity assay kit (Cayman Chemical Company, Ann Arbor, MI, USA) as per the manufacturer's instructions, using 15 lL of each
